Cerebral hypoperfusion in pulmonary arterial hypertension: Association with right ventricular dysfunction and risk stratification
Therapeutic Advances in Respiratory Disease · 2026
DOI: 10.1177/17534666261485141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2026. Verfasst von Peng Hou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Cerebrovascular Circulation, Ventricular Dysfunction, Right, Pulmonary Arterial Hypertension, Ventricular Function, Right. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Guangzhou Health Science and Technology Project, Guangzhou Municipal Science and Technology Project, Ministry of Industry and Information Technology of the People’s Republic of China.
Abstract (Originalsprache)
Background
Pulmonary arterial hypertension (PAH) is a progressive disease that affects the central nervous system. The cardiopulmonary-brain axis hypothesis links right ventricular dysfunction to cerebral hypoperfusion, yet the association between regional cerebral blood flow (CBF) alterations, right heart dysfunction, and the clinical utility of CBF for risk stratification remains poorly understood.
Objectives
To investigate the association between CBF and right heart dysfunction in patients with PAH, and to evaluate the potential of CBF as a non-invasive biomarker for risk stratification.
Design
Cross-sectional, retrospective study.
Methods
Thirty PAH patients and 51 age- and sex-matched healthy controls (HCs) were retrospectively identified. Brain MRI data, including 3D arterial spin labeling (ASL) at 3.0 T for CBF quantification were analyzed. For the PAH cohort, clinical assessment included right heart catheterization (RHC) and transthoracic echocardiography (TTE) to evaluate the structure of the right ventricle (RV) and hemodynamics. Patients were stratified into low and intermediate/high-risk groups according to the 2022 ESC/ERS guidelines. Receiver operating characteristic (ROC) analysis was used to evaluate the discriminatory value of CBF for risk stratification. Generalized Linear Models were applied to analyze associations between CBF, cardiac and hemodynamic parameters, and neuropsychological metrics.
Results
Compared with HCs, PAH patients exhibited significant regional hypoperfusion, predominantly in the right hippocampus, frontal gyri, and insula. Regional CBF values correlated inversely with RV area (systolic RV area and right caudate: r = -0.569, P = 0.006, systolic RV area and right thalamus: r = -0.587, P = 0.004, diastolic RV area and right caudate: r = -0.513, P = 0.012, diastolic RV area and right thalamus: r = -0.545, P = 0.007) and septal thickness (right superior frontal gyrus: r = -0.528, P = 0.015, left anterior cingulate: r = -0.495, P = 0.024). Notably, intermediate/high-risk patients demonstrated significantly lower CBF compared to low-risk patients, particularly in the parietal and frontal cortices. ROC analysis indicated that regional CBF, in addition to patient sex and age, could distinguish intermediate/high-risk patients from low-risk patients (right superior frontal region: AUC = 0.793, Sensitivity = 71%). Additionally, reduced CBF in the insula was associated with lower Mini-Mental State Examination (MMSE) scores.
Conclusion
This study demonstrates that cerebral hypoperfusion in PAH is closely associated with right ventricular dysfunction and disease severity. ASL-derived CBF holds promise as a non-invasive biomarker to refine risk stratification, offering novel insights into the cardiopulmonary-brain interaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated…
- Shanghai United Imaging Healthcare Advanced Technology Research Institute Co., Ltd., Shanghai, China.
ORCID-Profile: Peng Hou, Xinlu Wang
Förderung
- The Guangzhou Health Science and Technology Project
- Guangzhou Municipal Science and Technology Project
- Ministry of Industry and Information Technology of the People’s Republic of China
Zitieren
APA
Hou, P., Ke, M., Jiang, Q., Lai, N., Zhong, S., Zhao, R., Sun, C., Wang, G., Zhang, J., Geng, Y., Fu, Y., Liu, C., & Wang, X. (2026). Cerebral hypoperfusion in pulmonary arterial hypertension: Association with right ventricular dysfunction and risk stratification. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666261485141
Vancouver
Hou P, Ke M, Jiang Q, Lai N, Zhong S, Zhao R, et al. Cerebral hypoperfusion in pulmonary arterial hypertension: Association with right ventricular dysfunction and risk stratification. Therapeutic Advances in Respiratory Disease. 2026. doi:10.1177/17534666261485141
BibTeX
@article{Hou2026,
author = {Hou, Peng and Ke, Miao and Jiang, Qian and Lai, Ning and Zhong, Shaonan and Zhao, Ruiyue and Sun, Chang and Wang, Guanli and Zhang, Jiahui and Geng, Yiqiang and Fu, Yimin and Liu, Chunli and Wang, Xinlu},
title = {Cerebral hypoperfusion in pulmonary arterial hypertension: Association with right ventricular dysfunction and risk stratification},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2026},
doi = {10.1177/17534666261485141}
}
EUVIMED